The impact of the tested material on the levels of antiapoptotic BCL-2 protein in human breast cancer cell lines was assessed using the MuseTM Bcl-2 Activation Dual Detection Assay (Merck Millipore, Billerica, MA, USA) (representative plots in Figure S5). This evidence concerns the gene BCL2 and breast cancer.